The relationship between serum lipid parameters and renal frame count in hypertensive patients with normal renal functions Normal böbrek işlevi olan hipertansif hastalarda serum lipit parametreleri ile renal kare sayıları arasındaki ilişki Objective: Atherosclerosis can contribute to renovascular disease, and high cholesterol level is an independent risk factor for disease progression. Renal frame count (RFC) is an objective angiographic method of measuring macrovascular blood flow in the main renal artery and its segmental branches. The aim of the present study was to demonstrate relationship between serum lipid parameters and RFC.
s the major contributor to cardiovascular disease, atherosclerosis is among the most important reasons for mortality all over the world. Atherosclerosis is a progressive disease, especially in patients with diabetes and multiple cardiovascular disease risk factors, such as hyperlipidemia. [1] Atherosclerotic renal artery stenosis (RAS), as a part of cardiovascular disease spectrum, is the most common cause of secondary hypertension. [1] [2] [3] Coronary angiography performed in patients exhibiting severe hypertension, unexplained kidney failure, acute pulmonary edema with hypertension, or severe atherosclerosis, but who were not suspected of having RAS, revealed incidence of significant RAS of 14.3%. [4] At glomerular level, atherosclerotic process can also contribute to renal disease. [5] Serum lipids, as an important traditional risk factor, play an important role in pathogenesis of both coronary artery disease and renal artery atherosclerosis. [5] Correlation between progression of renal disease and dyslipidemia has been suggested in some experimental and clinical studies, and in humans, higher plasma cholesterol and triglyceride levels have been shown to be independent risk factors for progression of renal disease. [5] Renal frame count (RFC) is an objective angiographic method to quantify renal perfusion based on macrovascular blood flow in the main renal artery and its segmental branches as well as microvascular resistance of the cortex and medulla. [6] Aggressive management of cardiovascular risk factors, such as serum lipids, before overt renal artery atherosclerosis and renal failure occur may be a new focus.
In the present study, relationship between serum lipid parameters and RFC in hypertensive patients without critical renal artery stenosis was evaluated.
METHODS
This study was designed as a cross-sectional observational study of 116 hypertensive patients (blood pressure ≥140/90 mmHg despite treatment with 2 or more antihypertensives) who were admitted to our outpatient clinic between August 2012 and February 2015 and referred for coronary angiography with suspicion of stable coronary artery disease and eligible for selective renal angiography. All hospital archive data about pre-coronary angiography period of participants was examined. Demographic characteristics (age, gender) of the patients and risk factors, such as hypertension, diabetes mellitus, smoking, family history, and biochemical and hemogram values, were recorded.
Blood samples were collected to examine whole blood count, serum glucose, lipid profile, and renal function (blood urea nitrogen and creatinine) tests using Abbott Architect C16000 auto analyzer (Abbott Laboratories, Lake Bluff, IL, USA). Total and differential leukocyte counts were measured with automated hematology analyzer (Beckman Coulter, Inc., Brea, CA, USA). Creatinine clearance was calculated with Cockroft-Gault formula: (140-age) x mass (in kilograms) x (0.85 if female) / 72 x serum creatinine (in mg/dL).
Transthoracic echocardiography was performed at admission to determine left ventricular ejection fraction and presence of valvular disease (Vivid 7; GE Healthcare, Inc., Chicago, IL, USA). Selective coronary angiography was performed using the Judkins technique through right femoral artery.
Severity of coronary artery disease was established using the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) and Gensini scores. SYNTAX score of the patients was calculated by 2 invasive cardiologists using Web-based computer program (http://www.syntaxscore.com). [7] Gensini scores were calculated in a similar manner. According to the scoring system designed by Gensini, 1 point is given for stenosis of 0% to 25%, 2 points for 25% to 50% stenosis, 4 points for 50% to 75% stenosis, 8 points for 75% to 90% stenosis, 16 points for 90% to 99% stenosis, and 32 points for total occlusion. Final score is obtained multiplying degree of angiographic stenosis by coefficients predefined for each main coronary artery segment and addition of the sums. [8] Selective renal angiography of both renal arteries was performed with 6F right Judkins catheter. RFC was measured according to method described by Mulumudi et al. [6] Cineangiographic frames were taken at rate of 30 frames per second from time contrast dye reached proximal RA (contrast filling the transverse diameter of the artery) to distal landmark of the smallest cortical branch for each kidney. Mean RFC was calculated as arithmetic mean of right and left RFC.
Individuals with ≥30% RAS and those under statin therapy were excluded. Additionally, patients with chronic renal failure, ejection fraction <50%, valvular disease, previous renal artery disease, or history of renal stent were also excluded. The patients were allocated into 2 groups according to their serum lowdensity lipoprotein (LDL) and total cholesterol (TC) levels. Group 1 comprised 60 patients with serum LDL <130 mg/dL and Group 2 consisted of 56 indi- viduals with serum LDL ≥130 mg/dL. There were 52 and 64 patients in TC-based groups of TC <200 mg/ dL and ≥200 mg/dL, respectively.
All participants were informed about the study, and written consent was provided. The local ethics committee approved the study protocol and study performance complied with the Declaration of Helsinki.
Statistical analysis
Continuous variables were presented as mean±SD, while categorical variables were provided as percentages. Kolmogorov-Smirnov test was used to verify normality of distribution of continuous variables. Statistical analysis to determine difference in clinical data between 2 groups was performed using 2-sided Student's t-test. Categorical variables were compared Table 2 ). Scatter plot graphics of significant correlations between mean RFC and the above parameters can be seen in Figures 1 to 4 . In multivariate analysis, LDL level, TC, smoking packyears, and creatinine clearance were demonstrated to be independent predictors of RFC (Table 3) .
DISCUSSION
Results of this study indicate that serum lipid parameters may be related to RFC in hypertensive patients without significant renal arterial atherosclerotic lesions. Additionally, smoking period defined as packyears and serum LDL level were found to be independent predictors of RFC.
There are several studies indicating role of increased serum lipids in atherosclerotic process and nephropathy. In a Danish study, serum cholesterol level was demonstrated to be predictive for progression of diabetic nephropathy in 301 type 1 diabetes patients who had overt nephropathy. [5, 9] Circulating lipids bind to extracellular matrix molecules and undergo oxidation, which increases formation of reactive oxygen species, such as superoxide anion and hydrogen peroxide. [10, 11] As a result, actions of endothelium-derived perfusion. [1] In that study, high RFC value before renal artery stenting was accompanied by low creatinine clearance, which is indicator of glomerular filtration rate (GFR). This is an important finding that indicates role of high RFC as surrogate marker in clinical setting of decreased GFR. As a result of these studies, RFC can be assumed to be a practical measure of renovascular function.
In our study, patients with chronic hypertension using 2 or more antihypertensive drugs were evaluated. Significantly increased RFC in patients with LDL >130 mg/dL and TC >200 mg/dL may raise the need for more aggressive or earlier lipid-lowering therapy in these patient cohorts. Our findings regarding serum lipid parameters and RFC are interesting, as there was no overt renal failure or decrease in GFR beyond physiological limits. RFC was found to increase as exposure to smoking defined as pack-years. Similar to the catastrophic role of smoking in atherosclerotic coronary artery disease, it may have cumulative deleterious effect on renal functions, both at macro-and microvascular level. It has previously been reported that smoking is one of the most important factors in pathogenesis of hypertensive nephropathy. [20] [21] [22] In study conducted by Muhlhauser, risk of developing progressive kidney disease in diabetics who were smokers was much higher than for nonsmokers. [23] Additionally, relationship between chronic smoking and impairment of renal function, which was independent of age, has also been reported in studies. [24, 25] Research of Regalado et al. indicated that smoking was the strongest independent risk factor for decrease in renal function in patients with severe essential hypertension. [26] In hypertensive patients, serum LDL, TC, and smoking pack-years were observed to be independent predictors of RFC in our study. Also, as a negatively independent predictor of RFC, creatinine clearance, a strong indicator of GFR, provides rationale to use RFC as a surrogate marker of GFR. These findings are important and may be useful in clinical practice to encourage smoking cessation, lifestyle and dietary modifications, and earlier initiation of antihyperlipidemic therapy using lower cut-off limits in hypertensive patients.
Study limitations
The major limitation of the current study is the relatively small sample size. Lack of assessment of urinary microalbumin to determine subtle renal failure vasodilators/growth inhibitors, such as prostacyclin and nitric oxide, decrease. This, in turn, leads to increased production of endothelium-derived vasoconstrictors/growth promoters, such as angiotensin II, endothelin-1, and plasminogen activator inhibitor-1, which has significant vascular and renal pathophysiological effects. [5] Phagocytosis of oxidized lipids by macrophages results in formation of foam cells that secrete cytokines, causing more macrophages to accumulate in the lesion and influence lipid deposition, endothelial cell function, and vascular smooth muscle cell proliferation. [5] Glomerular cells share some characteristics of atherosclerotic vessel wall endothelial cells, which lead progression of atherosclerosis and chronic kidney disease. [12] A rat study reported that hyperlipidemia increased glomerular and tubulointerstitial infiltration and aggravated glomerulosclerosis. [5, 13] Another study with large nondiabetic population demonstrated positive and significant relationship between metabolic syndrome and risk for chronic renal disease and microalbuminuria. [14] In some studies, lipid-lowering therapy was reported to improve renal functions. [15] [16] [17] Satirapoj et al. reported that simvastatin treatment was associated with decrease in proteinuria in chronic kidney disease patients in addition to its lipid-lowering function. [16] Beneficial effects of statins may be result of inhibition of proliferation of cells such as mesangial, renal tubular, and vascular smooth muscle cells, and modulation of inflammatory response, inhibition of macrophage recruitment, activation, and fibrosis activity. [17] Although exact mechanism remains unclear, proliferation/apoptosis balance, down-regulation of inflammatory chemokines, and cytogenic messages mediated by Ras superfamily of GTPases may play some role in beneficial effects of lipid-lowering therapy. [15, 17] However, data are scant and large-scale clinical trials are needed. RFC, defined by Mulumudi et al., can be used as an indicator of renal perfusion, which is an indirect marker of renal function. [6] For optimal kidney perfusion, functional macrovascular and microvascular renal blood flow is required. [6, 1819] Nuclear scintigraphy has traditionally been used to assess renal perfusion, and recently, computerized tomography, positron emission tomography, magnetic resonance imaging, and contrast-enhanced Doppler ultrasonography have been utilized to evaluate renal blood flow. [6] Mahmud et al. demonstrated that RFC decreased significantly after renal artery stenting, indicating recovery of renal is another limitation. Also, we could not assess renal function with renal Doppler ultrasonography or renal blush grade, which would have added some much power to our statistical analyses. Large-scale studies that include antilipidemic therapy with follow-up renal angiograms in this patient cohort would be complimentary.
Conclusion
We can conclude that in hypertensive patients with normal GFR and renal function, serum LDL and TC levels may be predictors of increased RFC or decreased renal perfusion. In addition to serum lipid parameters, as traditional risk factor, smoking is an independent predictor of decreased renal perfusion. As a result, aggressive lipid-lowering therapy and smoking cessation may help to reduce risk of overt kidney failure by increasing renal perfusion.
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